Frontlight ResearchEarly access
Ovarian cancer trials in Australia
59 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleSafety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors
- Where
- Adelaide, Darlinghurst, Melbourne, Nedlands, Randwick, South Brisbane, Waratah
- Age
- 18 years and over
- People
- 60
- Run by
- Myeloid Therapeutics
See details and how to joinNCT07334119 - No phaseNot yet taking people in AustraliaEvaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC)
- Where
- Adelaide, Box Hill, Camperdown, Clayton, Hobart, Melbourne, Nedlands, Sydney
- Age
- 18 years to 42 years
- People
- 75
- Run by
- Peter MacCallum Cancer Centre, Australia
See details and how to joinNCT07527819 - No phaseTaking peopleTUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
- Where
- Adelaide, Brisbane, Melbourne, Perth, Richmon, St Albans, Sydney
- Age
- 25 years to 50 years
- People
- 3,000 worldwide
- Run by
- University Medical Center Nijmegen
See details and how to joinNCT04294927 - Phase 1/2Taking peopleOpen-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
- Where
- Frankston, Parkville, South Brisbane
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- Incyclix Bio
See details and how to joinNCT05735080 - Phase 1Taking peopleStudy of Intratumoral IVX037 in Patients With Advanced or Metastatic Solid Tumours
- Where
- Adelaide, Melbourne, Sydney
- Age
- 18 years to 85 years
- People
- 70
- Run by
- ImmVirx Pty Ltd
See details and how to joinNCT05427487 - No phaseTaking peopleEARLY Study: Evaluating the Specificity and Feasibility of the EARLY Biomarker Panel for Ovarian Cancer Detection
- Where
- Brisbane
- Age
- 50 years to 74 years
- People
- 1,500
- Run by
- Queensland Centre for Gynaecological Cancer
See details and how to joinNCT07491081 - Phase 1/2Taking peopleEarly Phase Study of KESONOTIDE™in Participants With Solid Tumours
- Where
- Kogarah, Liverpool, Miranda
- Age
- 18 years and over
- People
- 80
- Run by
- Filamon LTD
See details and how to joinNCT06926075 - Phase 1Taking peopleA Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
- Where
- South Brisbane
- Age
- 18 years and over
- People
- 263 worldwide
- Run by
- OnCusp Therapeutics, Inc.
See details and how to joinNCT06234423 · EU 2024-519862-33-01 - Phase 2Taking peopleCATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
- Where
- Bedford Park, Blacktown, Chermside, Clayton, Perth
- Age
- 18 years and over
- People
- 230 worldwide
- Run by
- TORL Biotherapeutics, LLC
See details and how to joinNCT06690775 · EU 2024-517190-24-00